HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    

Zacks Mutual Fund Rank
Did you know that Zacks now ranks mutual funds? We've reinvented the way mutual funds are rated.   Try it now.
Quote:
Login Free Membership
Search:

 
Analyst Blog  

CDC’s License Revenue to Drop

By: Zacks Equity Research
October 16, 2009 | Comments: 0
Recommended this article (1)
Print    Share

CDC Software Corp (CDCS), a wholly owned subsidiary of CDC Corp. (CHINA - Snapshot Report) said that it expects a decline in its license revenue. The company expects software license revenue to fall in the range of $7.4 – $7.6 million in the third quarter of 2009. The mid-point of the range is a decline of 37% from the year-ago period and 4% from the previous quarter. 

We believe this fall is mainly due to the declining business activity the company felt during this economic downturn, which had a negative impact on the overall enterprise software industry. 

Despite the sequential and year-over-year decline in license revenue, the overall revenue estimates are in line with the First Call Consensus estimates of $7.4 million. The company also said that the license revenue from new logo business increased to 24% in the forecasted quarter, up from 12% reported in the previous quarter. 

CDC Software’s top 10 deals in the quarter included six deals in the food and beverage and financial services/insurance markets. 

CDC Software is a leading provider of enterprise software applications and services. The company generates software revenues from the sale of software licenses and the maintenance and services for such software licenses. CDC has historically achieved 15.0% to 20.0% organic license revenue growth, which may be among the strongest in the industry. 

With a strong organic growth in its software business, we believe CDC is poised to grow. With a continuous focus on vertical industries, cost reduction initiatives in its software segment, new launches and upgrades in its product line as well as integration efforts, CDC should develop a significant competitive advantage in 2009 and beyond. 

Also, an increase in license bookings and a strong pipeline of sales opportunities at CDC Software should drive growth. Moreover, the company remained upbeat on its fourth quarter of 2009 outlook but did not provide any specific guidance.

Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Free Stock Analysis From Zacks
  Includes Zacks Long-Term Recommendation and Target Price
Read/Post Comments (0) | Recommended this article (1)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Feb 10, 2010 07:54 am ET
DJIA 10058.64  0.00 0.00%
NASD 2150.87  0.00 0.00%
S&P 500 1070.52  0.00 0.00%